People who used while dried cannabis flowers or cannabis with higher levels of THC had the greatest analgesic response to pain. Those who used CBD reported lower levels of pain relief.
The effect cannabidiol has on Lennox-Gastaut syndrome may be explained by the drug-drug interaction between CBD and anti-seizure medication.
Findings show new therapy has potential to help the brain as it reacts to stroke’s harmful effects. Researchers at the...
New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to...
Researchers have found that some second-trimester markers for Down’s syndrome detected by ultrasound increase the risk of giving birth to a child with the condition. The findings could help address the risks pregnant women face in having a child with Down’s syndrome.
Using purified botanical cannabidiol (CBD) to treat mouse models of Davet syndrome improved mortality and reduced behavioral symptoms associated with the condition.
Almost 1 in 5 people now use opioids to treat migraines. Researchers say a growing number of patients are using opioids to replace medications approved and specially designed to treat migraines, despite knowing the risks of opioid use.
Coronavirus patients treated with chloroquine or hydroxychloroquine are significantly more likely to experience ventricular arrhythmias than those who were treated with other medications. The study also revealed that out of 100,000 COVID-19 patients who were hospitalized, the 15,000 who received hydroxychloroquine were more likely to have worse health outcomes than those treated with other drugs.
Classical music exposure paired with ibuprofen reduced response to inflammation pain by 93%, compared to exposure to the medication alone in mouse models of pain. For those exposed to just music, researchers report a 77% reduction in surgical pain.
Researchers discover a new class of experimental drug like small molecules show promise in targeting a brain enzyme to prevent early memory loss in Alzheimer's disease.
Alpha synuclein's non-amyloidal component (NAC) aids the protein's movement through axons. When the NAC region is removed, alpha-synuclein did not move within axons.
Study provides first potential targets for effective immune responses against COVID-19. The findings provide essential information for vaccine design against SARS-CoV-2.
